Board of Directors

Rebecca Rosh is a strategic investment executive with extensive international experience in the financial and healthcare sectors. Her expertise lies in M&A, strategic investment, and global business development, with a primary focus on medical devices, biotechnology, and the life sciences industry. Throughout her career, she has been deeply involved in cross-border investments, capital markets, and strategic partnerships, dedicated to driving innovation in medical technology, fostering corporate growth, and creating commercial synergies between the Asian and North American markets.

Rebecca holds a Master’s degree in Finance from NYU. Early in her career, she gained foundational experience in financial analysis and investment banking at Morgan Stanley and UBS, before transitioning her professional focus toward strategic investment, M&A, and international business development within the healthcare sector. Additionally, she is active in family office investments, where she explores long-term opportunities in medical technology, artificial intelligence, and emerging financial technologies